Current application and research directions for partial-breast irradiation

ONCOLOGY

Volumn 21, Issue 4, 2007, Pages 449-461

  Goyal, Sharad ^a   Kearney, Thomas ^a   Haffty, Bruce G ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IRIDIUM 192; METHOTREXATE; PREDNISONE;

ACCELERATED PARTIAL BREAST IRRADIATION; BALLOON CATHETER; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DEVICE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTERMETHOD COMPARISON; INTERSTITIAL RADIATION; INTRAOPERATIVE RADIOTHERAPY; LOW ENERGY RADIATION; PARTIAL MASTECTOMY; PATIENT SELECTION; RADIATION DOSE; REVIEW; STANDARD; TREATMENT DURATION; TREATMENT INDICATION;

BRACHYTHERAPY; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; META-ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 34247521478     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002.
2. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002.
3. Blichert-Toft M, Rose C, Andersen JA, et al: Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 19-25, 1992.
4. Poggi MM, Danforth DN, Sciuto LC, et al: Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute randomized trial. Cancer 98:697-702, 2003.
5. van Dongen JA, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000.
6. Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88:1659-1664, 1996.
7. Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002.
8. Liljegren G, Holmberg L, Bergh J, et al: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326-2333, 1999.
9. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001.
10. Winzer KJ, Sauer R, Sauerbrei W, et al: Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40:998-1005, 2004.
11. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005.
12. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96:115-121, 2004.
13. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998.
14. Julien JR Bijker N, Fentiman IS, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533, 2000.
15. Vrieling C, Collette L, Fourquet A, et al: The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "Boost Versus No Boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 45:677-685, 1999.
16. Vrieling C, Collette L, Fourquet A, et al: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'Boost vs No Boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219-232, 2000.
17. Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097-1101, 1992.
18. Lazovich DA, White E, Thomas DB, et al: Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433-3438, 1991.
19. Mann BA, Samet JM, Hunt WC, et al: Changing treatment of breast cancer in New Mexico from 1969 through 1985. JAMA 259:3413-3417, 1988.
20. Ballard-Barbash R, Potosky AL, Harlan LC, et al: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726, 1996.
21. Kelemen JJ 3rd, Poulton T, Swartz MT, et al: Surgical treatment of early-stage breast cancer in the Department of Defense healthcare system. J Am Coll Surg 192:293-297, 2001.
22. Whelan T, Levine M, Gafni A, et al: Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol 17:1727-1735, 1999.
23. Athas WF, Adams-Cameron M, Hunt WC, et al: Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92:269-271, 2000.
24. Schroen AT, Brenin DR, Kelly MD, et al: Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 23:7074-7080, 2005.
25. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004.
26. Smith BD, Gross CP, Smith GL, et al: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98:681-690, 2006.
27. Obedian E, Fischer DB, Haffty BG: Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18:2406-2412, 2000.
28. Smith TE, Lee D, Turner BC, et al: True recurrence vs. New primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:1281-1289, 2000.
29. Recht A, Come, SE, Troyan, S, et al: Local-regional recurrence after mastectomy or breast-conserving therapy, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast, 2nd ed, pp 731-748. Philadelphia, Lippincott Williams & Wilkins, 2000.
30. Fisher B, Anderson S: Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 18:63-69, 1994.
31. Holli K, Saaristo R, Isola J, et al: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 84:164-169, 2001.
32. Sector resection with or without post-operative radiotherapy for stage I breast cancer: A randomized trial. The Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst 82:1851, 1990.
33. Clark RM, McCulloch PB, Levine MN, et al: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683-689, 1992.
34. Holland R, Connolly JL, Gelman R, et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113-118, 1990.
35. Holland R: Pathological target definition in patients selected for APBI (abstract 170). Radiother Oncol 81(suppl 1):S65-S66, 2006.
36. Arthur DW, Vicini FA, Kuske RR, et al: Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy 2:124-130, 2003.
37. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82C randomised trial. Lancet 353:1641-1648, 1999.
38. Ragaz J, Olivotto IA, Spinelli JJ, et al: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116-126, 2005.
39. Zwicker RD, Arthur DW, Kavanagh BD, et al: Optimization of planar high-dose-rate implants. Int J Radiat Oncol Biol Phys 44:1171-1177, 1999.
40. Kuske RR, Bolton J, Wilenzick RM, et al: Brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer (abstract). Int J Radiat Oncol Biol Phys 30:245, 1994.
41. King TA, Bolton JS, Kuske RR, et al: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1,2) breast cancer. Am J Surg 180:299-304, 2000.
42. Vicini FA, Kestin L, Chen P, et al: Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95:1205-1210, 2003.
43. Kuske RR, Winter K, Arthur DW, et al: A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: Toxicity analysis of Radiation Therapy Oncology Group 95-17 (abstract). Int J Radiat Oncol Biol Phys 54:87, 2002.
44. Arthur DW, Winter K, Kuske RR, et al: A phase II trial of brachytherapy alone following lumpectomy for select breast cancer: Tumor control and survival outcomes of RTOG 95-17 (abstract). Int J Radiat Oncol Biol Phys 66:S29-S30, 2006.
45. Fentiman IS, Deshmane V, Tong D, et al: Caesium(137) implant as sole radiation therapy for operable breast cancer: A phase II trial. Radiother Oncol 71:281-285, 2004.
46. Fentiman IS, Poole C, Tong D, et al: Iridium implant treatment without external radiotherapy for operable breast cancer: A pilot study. Eur J Cancer 27:447-450, 1991.
47. Poti Z, Nemeskeri C, Fekeshazy A, et al: Partial breast irradiation with interstitial 60co brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 58:1022-1033, 2004.
48. Polgar C, Fodor J, Major T, et al: Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects. Strahlenther Ontol 178:597-606, 2002.
49. Polgar C, Major T, Somogyi A, et al: Sole brachytherapy of the tumor bed after breast conserving surgery: A new radiotherapeutic strategy for patients at low risk of local relapse. Neoplasma 46:182-189, 1999.
50. Polgar C, Major T, Fodor J, et al: High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173-1181, 2004.
51. Zannis V, Beitsch P, Vicini F, et al: Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry trial. Am J Surg 190:530-538, 2005.
52. Keisch ME, Vicini FA, Beitsch P, et al: Two year actuarial analysis of 198 patients with dcis treated with accelerated partial breast irradiation (APBI): Efficacy, cosmesis and toxicity in patients on the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry trial. Int J Radiat Oncol Biol Phys 66:S213, 2006.
53. Cuttino LW, Arthur DW, Keisch M, et al: Multi-institutional experience using the MammoSite Radiation Therapy System (RTS) in the treatment of early-stage breast cancer: 2 year results. Int J Radiat Oncol Biol Phys 66:S30-S31, 2006.
54. Benitez PR, Streeter O, Vicini F, et al: Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: A phase II clinical study. Am J Surg 192:427-433, 2006.
55. Ellerin BE, Seidenfeld J, Formenti SC: A systematic review of post-lumpectomy radiation therapy regimens (abstract 683). Proc Am Soc Clin Oncol 23:47, 2004
56. Suh WW, Pierce LJ, Vicini FA, et al: A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 62:790-796, 2005.
57. Baglan KL, Sharpe MB, Jaffray D, et al: Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 55:302-311, 2003.
58. Vicini FA, Remouchamps V, Wallace M, et al: Ongoing clinical experience utilizing 3d conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57:1247-1253, 2003.
59. Vicini F, Winter K, Straube W, et al: A phase I/II trial to evaluate three-dimensional conformai radiation therapy confined to the region of the lumpectomy cavity for stage i/ii breast carcinoma: Initial report of feasibility arid reproducibility of Radiation Therapy Oncology Group (RTOG) study 0319. Int J Radiat Oncol Biol Phys 63:1531-1537, 2005.
60. Wernicke AG, Gidea-Addeo D, Magnolfi C, et al: External beam partial breast irradiation following breast-conserving surgery: Preliminary results of cosmetic outcome of NYU 00-23 (abstract 54). Int J Radiat Oncol Biol Phys 66(suppl S):S32, 2006.
61. Hall E: Radiobiology for the Radiologist, 5th ed. Philadelphia, Lippincott Williams & Wilkins, 2000.
62. Vaidya JS, Tobias JS, Baum M, et al: Intraoperative radiotherapy for breast cancer. Lancet Oncol 5:165-173, 2004.
63. Veronesi U, Gatti G, Luini A, et al: Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 138:1253-1256, 2003.
64. Tobias JS, Vaidya JS, Keshtgar M, et al: Reducing radiotherapy dose in early breast cancer: The concept of conformal intraoperative brachytherapy. Br J Radiol 77:279-284, 2004.
65. Huang J, Barbera L, Brouwers M, et al: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:555-563, 2003.
66. Bellon JR, Come SE, Gelman RS, et al: Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial. J Clin Oncol 23:1934-1940, 2005.
67. Obedian E, Haffty BG: Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6:28-33, 2000.
68. Park CC, Mitsumori M, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675, 2000.
69. Berle L, Wazer DE, Graham R, et al: Toxicity, local control and cosmesis after interstitial partial breast HDR brachytherapy alone for T1/T2 breast cancer (abstract 74). Radiother Oncol 71(suppl):S37, 2004.
70. Arthur DW, Koo D, Zwicker RD, et al: Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 56:681-689, 2003.
71. Zellars R, Frassica D, Stearns V, et al: Partial breast irradiation (PBI) concurrent with adjuvant dose-dense doxorubicin and cyclophosphamide (ddac) chemotherapy in early-stage breast cancer: Preliminary safety results from a feasibility trial (abstract 10675). J Clin Oncol 24(18S):582s, 2006.
72. Haffty BG, Vicini FA, Beitsch P, et al: Timing of chemotherapy following accelerated partial breast irradiation: Analysis of the American Society of Breast Surgeons MammoSite registry trial (abstract 4081). Breast Cancer Res Treat 100(suppl 1), 2006.